Form 4 for CTXR Citius Pharmaceuticals, Inc.
Accepted 2024-08-30 00:00:00 ET · period of report 2024-03-13 · accession 0001213900-24-074506 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-30 | 2024-03-13 | CTXR | Holuka Eugene Myron | Dir | M - OptEx | $0.02 | +2,415 | 2,415 | New | +$48.30 |
| D | 2024-08-30 | 2024-03-13 | CTXR | Holuka Eugene Myron | Dir | F - Tax | $0.75 | -48 | 2,367 | -2% | -$36 |
| D | 2024-08-30 | 2024-03-13 | CTXR | Holuka Eugene Myron | Dir | M - OptEx | $0.00 | -2,415 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-13 | M | A | 2,415 | $0.02 | 2,415 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-13 | F | D | 48 | $0.75 | 2,367 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Purchase Common Stock) | 2024-03-13 | M | D | 2,415 | $0.00 | 0 | D | $0.02 · 2017-04-14 to 2024-04-14 | 2,415 Common Stock |